Medindia LOGIN REGISTER
Medindia
Advertisement

New Guideline For Stepping Down The Asthma Treatment Made

by Rishika Gupta on January 27, 2019 at 4:45 PM
Highlights:
  • New guideline for stepping down the asthma therapy in well maintained asthma patients has finally been made
  • This guideline will addresses how to reverse the process for patients whose asthma has been well controlled for at least three months - or longer for the highest risk patients.
  • It is believed to help health care professionals understand how to identify when a patient is ready to step down their treatment, and what the process might involve.

New Guideline For Stepping Down The Asthma Treatment Made

A new guideline from the American College of Allergy, Asthma, and Immunology (ACAAI), offers an "operation manual" for stepping down asthma therapy. It is said to help clinicians understand when treatment should be stepped down, and how.

When asthma symptoms improve, there's the reason for celebration by both allergist and patient. But once symptoms are better, how do health care practitioners go about stepping down asthma medication to make sure a patient's needs are still met? The Asthma Controller Step Down Yardstick, a new guideline from the American College of Allergy, Asthma, and Immunology (ACAAI), offers an "operation manual." It helps health care professionals understand how to identify when a patient is ready to step down their treatment, and what the process might involve.

Advertisement


"There is a gap in information when it comes to guiding allergists and other health practitioners through the process of stepping down controller therapy," says allergist Bradley Chipps, MD, immediate ACAAI past president and lead author of the guideline. "We have yardsticks that address stepping up asthma controller medication, but this document addresses how to reverse the process for patients whose asthma has been well controlled for at least three months - or longer for the highest risk patients."

The guideline outlines both reasons for, and reasons not to consider stepping down treatment.

Consider stepping down treatment to:


Re-assess a current diagnosis of asthma.
Decrease the potential adverse effects of asthma medications.
Address patient and family preferences about taking medications.
Reduce the burden of treatment (e.g., time to take medications, remembering to take medications, having to take medications at work or school).
Reduce the costs of treatment.
Simplify therapy and enhance adherence with treatment.
Consider not stepping down treatment when:
Advertisement

Reducing asthma medication may lead to an increased risk of having an asthma exacerbation or loss of control.

It is unclear whether the patient is using his/her asthma medications as indicated (e.g., whether the patient has already self-reduced treatment). Seasonal maintenance of therapy is needed (e.g., during the patient's allergy season or viral season).

"Stepping down controller therapy serves several purposes," says allergist Leonard Bacharier, MD, co-author of the guideline. "It identifies the minimum effective treatment that will maintain well-controlled asthma based on both impairment and risk domains. And it minimizes the risk of adverse effects from higher doses of medication(s) than may be needed to maintain control. It can also simplify the patient's treatment regimen and may enhance adherence because reducing exposure to higher doses of medication(s) is generally consistent with patient values and preferences."

The guideline offers specific recommendations regarding appropriate medications and dosing for patients on step 2 through step 5 asthma therapy.

"Stepping down asthma therapy is an important component of managing patients with asthma, from the mildest end of the severity spectrum to the most difficult-to-treat patient," says Dr. Chipps. "Although current guidelines recommend stepping down therapy in a patient with stable asthma, the operational focus has been on how to step up treatment when asthma is inadequately controlled. This Yardstick provides recommendations for how to step-down therapy using guideline-based severity levels."

Source: Eurekalert
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Research News

Confronting the Painful Realities of Racial Bias in Health
Painful realities of racial discrimination and bias are increasingly acknowledged as harmful to the well-being.
Intricate Dance of Flaxseed, Gut Microbiome, and Breast Cancer Genes
Role of flaxseed in the relationship between gut microorganisms and mammary gland microRNAs has been uncovered by a new study.
MRNA Therapy's Promise for Chronic and Acute Liver Disease
New mRNA stem cell therapy, akin to COVID-19 vaccine tech, shows potential against chronic and acute liver diseases.
Could Light Therapy Be a Breakthrough for Alzheimer's?
Light therapy enhances sleep and psycho-behavioral symptoms in Alzheimer's patients with minimal side effects.
Does Twice Daily Stimulation Enhance Alzheimer's Mental Functions?
Electrical stimulation improves Alzheimer's patients' cognitive function and correlates with restored cortical plasticity.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

New Guideline For Stepping Down The Asthma Treatment Made Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests